Hngr(310)FC GMP3 campaign and octet method development

Active Awarded Last action

Contract number
75N91019F00140
Awardee
Awarding agency
Obligated
$9,231,560

Award facts

Opportunity
  • N02CO7240681 Solicitation number
Contract value 88% obligated
  • $9,231,560.00 Current, with exercised options
  • $10,530,557.00 Potential, with all options
Completion date 89% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00012 -$1,654,198
Other Administrative Action P00011 $0
Change Order P00010 $1,363
Change Order P00009 $2,794,696
Change Order P00008 · Neuresta drug substance manufacturing -$94,461
Supplemental Agreement for work within scope P00007 $1,645,800
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Exercise an Option P00003 $4,286,448
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $2,251,912
Show all 13

About this award

The National Center for Advancing Translational Sciences issued a delivery order to Leidos Biomedical Research Inc. on September 16, 2019, with a ceiling value of $10.5 million for GMP3 campaign and OCTET method development and NeuroSta drug substance manufacturing, with ultimate completion on September 15, 2027.

Work is performed at Frederick, MD. The order is priced on a cost-plus-fixed-fee basis. Malvern Panalytical Inc. is supplying an Aeris 600 W Research Edition X-ray diffraction system configured with copper X-ray tube, automated sample changer, ICDD PDF5+ database access, classroom training, and installation support.

Service Contract Inventory reporting across fiscal years 2021–2025 shows invoiced federal labor totaling approximately $3.5 million. FY2025 (most recent) reflects 1.4 FTEs across 2,914 contractor hours at a derived blended rate of $28.37 per hour. Subcontractor engagement in FY2025 accounted for 93 percent of contractor hours. The trend in derived hourly rates is declining across the reporting period, with significant year-over-year volatility reflecting the order's manufacturing and development cadence.

Subawards

Subcontractor Amount Awarded
Malvern Panalytical Inc. HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT Aeris 600 W Research Edition X-ray diffraction (XRD) system configured with a Copper X-ray tube. •… $141,295

Quick answers

Who was awarded contract 75N91019F00140?

75N91019F00140 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2019.

How much is contract 75N91019F00140 worth?

The government has obligated $9,231,560 on 75N91019F00140. Its potential value, with all options, is $10,530,557.

Which agency awarded contract 75N91019F00140?

National Cancer Institute (National Institutes of Health) awarded 75N91019F00140, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N91019F00140 an order under another contract?

Yes. 75N91019F00140 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91019F00140 competed?

The extent of competition for 75N91019F00140 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award